Varazdin General Hospital
Varaždin, HR-42000, Croatia
NCT Number: NCT01953302
Ventral hernias, primary and recurrent, are major surgical challenge. We aim to investigate efficacy of modified technique of ventral hernias repair: an "open intraperitoneal mesh" technique.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Varaždin, HR-42000, Croatia
We analyzed early postoperative complications (EPCs; wound infection, hematoma, and seroma) and late postoperative complications (recurrence) in 124 patients operated for IHs and recurrent IHs (RIHs) using our new technique. Our technique involved repairing hernias by preserving the hernia sac, which was later used to conceal the mesh that replaced the abdominal wall defect, thus dividing the mesh from subcutaneous tissue.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
We positioned mesh intraperitoneally so it can provide adequate mechanical support to the weakened abdominal wall. We also preserved hernia sack to conceal the mesh.
Other names: Proceed Surgical Mesh, VycrilTM,2-0 resorbing sutures
Time frame: four weeks after the surgery
we counted number of patinetns with wound infection, seroma, hematoma that occured in the early postoperative time
Time frame: up to 36 months after the surgery
Varazdin General Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07422584
Incisional Ventral Hernia
Chicago, Illinois, United States
View Trial DetailsNCT06314152
Chronic Pain, Disease Attributes
Nanchong, Sichuan, China
View Trial DetailsNCT05929378
Chronic Pain, Disease Attributes
Nanchong, Sichuan, China
View Trial DetailsNCT00478348
Disease Attributes, Hematoma
Lausanne, Canton of Vaud, Switzerland
View Trial Details